Journal of Neuromuscular Diseases· 2026Q1
Delving into the clinical and genetic spectrum of NLSDM: A case study
- 0citations
- Q1SCImago
- 2026year
Short summary
A novel homozygous PNPLA2 mutation, causing a single amino acid deletion in the ATGL LC3-interacting region (LIR) motif, was identified in a 42-year-old male with neutral lipid storage disease with myopathy (NLSDM), leading to widespread muscle weakness and impaired lipophagic flux without cardiac involvement.
AI-generated from the title and abstract; the full text is not read.
Key points
- A novel homozygous PNPLA2 mutation was identified in a 42-year-old male with NLSDM.
- The mutation involves a single amino acid deletion in the first ATGL LC3-interacting region (LIR) motif.
- This genetic alteration is predicted to disrupt ATGL-LC3 interaction, impairing lipolysis and lipophagy.
- The patient presented with myopathic symptoms affecting proximal, distal, axial, and facial muscles, but no cardiac abnormalities.
AI-generated from the title and abstract; the full text is not read.
Abstract
Mutations in the PNPLA2 gene, which encodes adipose triglyceride lipase (ATGL), are linked to neutral lipid storage disease with myopathy (NLSDM). This rare genetic disorder is marked by abnormal accumulation of neutral lipids in cytoplasmic lipid droplets, leading to muscle-related symptoms such as weakness, cramps and progressive myopathy in almost all patients, and cardiomyopathy in about half of the patients. Here, we report a novel PNPLA2 variant and the clinical and MRI findings of a 42-year-old Italian male with NLSDM, revealing a myopathic pattern involving both proximal and distal muscles of all four limbs, as well as axial and facial muscles, without detectable cardiac abnormalities. Genetic testing uncovered a novel PNPLA2 homozygous mutation, resulting in the deletion of a single amino acid in the first ATGL LC3-interacting region (LIR) motif. In addition, bioinformatic analyses predicted changes in mutated ATGL’s structure that could affect its enzymatic function and impair both lipolysis and lipophagy by disrupting ATGL-LC3 interaction. Western blot analysis confirmed a block in lipophagic flux. This study broadens our understanding of the genetic and clinical heterogeneity of NLSDM, highlighting the complexity of the disease.
The authors' abstract, as published at the source. Journal of Neuromuscular Diseases, 2026 · DOI ↗
Continue with a free account
Ask the paper: 3 free questions a day about this paper; save it, get its citation, new summaries every day for your field. Takeaways are Premium.
Continue free on the webSign in with Google or Apple; no card needed. You come back to this paper.
On your phone:
Field: Biochemistry (Biochemistry, Genetics and Molecular Biology)
BiochemistryBiochemistry, Genetics and Molecular Biology